856 related articles for article (PubMed ID: 26261539)
21. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
[TBL] [Abstract][Full Text] [Related]
22. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-21 expression is associated with overall survival in patients with glioma.
Wu L; Li G; Feng D; Qin H; Gong L; Zhang J; Zhang Z
Diagn Pathol; 2013 Dec; 8():200. PubMed ID: 24326156
[TBL] [Abstract][Full Text] [Related]
24. MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.
Hermansen SK; Dahlrot RH; Nielsen BS; Hansen S; Kristensen BW
J Neurooncol; 2013 Jan; 111(1):71-81. PubMed ID: 23104517
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
Wang L; Wu L; Wu J
J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
[TBL] [Abstract][Full Text] [Related]
26. Correlation of microRNA-10b upregulation and poor prognosis in human gliomas.
Ji Y; Wei Y; Wang J; Gong K; Zhang Y; Zuo H
Tumour Biol; 2015 Aug; 36(8):6249-54. PubMed ID: 25773393
[TBL] [Abstract][Full Text] [Related]
27. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
28. Low expression of miR-1231 in patients with glioma and its prognostic significance.
Wang H; Wu J; Luo WJ; Hu JL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8399-8405. PubMed ID: 30556881
[TBL] [Abstract][Full Text] [Related]
29. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
Tong YQ; Liu B; Zheng HY; Gu J; Liu H; Li F; Tan BH; Hartman M; Song C; Li Y
Oncotarget; 2015 Sep; 6(28):25024-33. PubMed ID: 26317904
[TBL] [Abstract][Full Text] [Related]
30. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
31. Reduced expression of miR-3653 in glioma and its correlations with clinical progression and patient survival.
Chen Y; Li ZH; Liu X; Liu GX; Yang HM; Wu PF
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6596-6601. PubMed ID: 31378901
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
[TBL] [Abstract][Full Text] [Related]
33. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
Sasayama T; Nishihara M; Kondoh T; Hosoda K; Kohmura E
Int J Cancer; 2009 Sep; 125(6):1407-13. PubMed ID: 19536818
[TBL] [Abstract][Full Text] [Related]
35. Tumor microRNA-335 expression is associated with poor prognosis in human glioma.
Jiang J; Sun X; Wang W; Jin X; Bo X; Li Z; Bian A; Jiu J; Wang X; Liu D; Hui X; Wang Y; Wang A; Ding L
Med Oncol; 2012 Dec; 29(5):3472-7. PubMed ID: 22644918
[TBL] [Abstract][Full Text] [Related]
36. Expression level of human miR-34a correlates with glioma grade and prognosis.
Gao H; Zhao H; Xiang W
J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
38. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
39. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
40. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]